| | | |
| A "heart failure profile" of serum and plasma markers? | M. Cowie (London, GB) | New strategies in the diagnosis of heart failure | 31 August 2003 |
| A randomised trial of occluded artery angioplasty after acute myocardial infarction (DECOPI) | P. Steg (Paris, FR) | Hot Line II Acute coronary syndromes/percutaneous coronary interventions 2 | 01 September 2003 |
| Antiplatelet treatment | R. Califf (Durham, US) | Therapeutic options in non ST segment elevation acute coronary syndromes | 01 September 2003 |
| Antithrombin treatment | K. Fox (Edinburgh, GB) | Therapeutic options in non ST segment elevation acute coronary syndromes | 01 September 2003 |
| Asymptomatic moderate mitral insufficiency (no flail leaflet but mitral prolapse) | R. Bonow (Chicago, US) | Challenging issues in valvular heart disease: applying the guidelines | 31 August 2003 |
| Candesartan in heart failure (CHARM programme) | C.B. Granger (Durham NC, US)J.J.V. McMurray (Glasgow, GB)S.Yusuf (Hamilton, CA)K.Swedberg (Gothenburg, SE)M.A. Pfeffer (Boston, US)
| Hot Line I Medical treatment / heart failure | 31 August 2003 |
| Cardiac resynchronisation and implantable cardioverter-defibrillators | A. Auricchio (Magdeburg, DE) | Management of advanced heart failure | 02 September 2003 |
| Diagnostic algorithms in heart failure | K. Swedberg (Gothenburg, SE) | New strategies in the diagnosis of heart failure | 31 August 2003 |
| Direct angioplasty: do we need pre-hospital treatment? | G. Montalescot (Paris, FR) | Optimal reperfusion therapy in acute myocardial infarction: the debate lives on | 01 September 2003 |
| Does pre-transportation treatment with tirofiban improve patency in acute myocardial infarction patients who are referred for percutaneous coronary intervention (ON-TIME)? | A. Van't Hof (Zwolle, NL) | Hot Line II acute coronary syndromes / percutaneous coronary interventions 2 | 01 September 2003 |
| Effects of an angiotensin-converting enzyme inhibitor, perindopril, on cardiovascular events in stable coronary artery disease patients (EUROPA) | K. Fox (London, GB)W.J. Remme (Rhoon, NL)
| Hot Line I Medical treatment / heart failure | 31 August 2003 |
| Efficacy and safety of long-term treatment with the oral direct thrombin inhibitor ximelagatran, in combination with acetylsalicyclic acid, in patients after acute myocardial infarction (ESTEEM) | L. Wallentin (Uppsala, SE) | Hot Line II Acute coronary syndromes/percutaneous coronary interventions 2 | 01 September 2003 |
| Experience from the Seven Countries study | D. Kromhout (Bilthoven, NL) | CVD Prevention | 31 August 2003 |
| How far to "magnetic resonance one stop shop?" | U. Sechtem (Stuttgart, DE) | New strategies in the diagnosis of heart failure | 31 August 2003 |
| Implementation of implantable cardioverter-defibrillator therapy for primary prevention - the European perspective. | G. Breithardt (Münster, DE) | Update on guidelines for pacemakers and implantable cardiac-defibrillators | 03 September 2003 |
| Invasive strategy in all patients? | K. Garratt (Rochester, US) | Therapeutic options in non-ST-segment elevation acute coronary syndromes | 01 September 2003 |
| Long distance transport, low volume centres: impact on the results of direct angioplasty | P. Widimsky (Praha 10, CZ) | Optimal reperfusion therapy in acute myocardial infarction: the debate lives on | 01 September 2003 |
| Management of the high-risk patient with angiotensin-converting enzyme inhibitors | S. Yusuf (Hamilton, CA) | Medical management of chronic coronary artery disease: an update | 01 September 2003 |
| Management of the high-risk patient with statins | S.C. Smith (Chapel Hill, US) | Medical management of chronic coronary artery disease: an update | 01 September 2003 |
| Management of the low-risk patient with angiotensin-converting enzyme inhibitors | M. Simoons (Rotterdam, NL) | Medical management of chronic artery disease: an update | 01 September 2003 |
| Mitral stenosis | A. Vahanian (Paris, FR) | Challenging issues in valvular heart disease: applying the guidelines | 31 August 2003 |
| Outcome of the non-polymeric paclitaxel eluting stent (DELIVER II) | E. Grube (Siegburg, DE) | Hot Line II acute coronary syndromes / percutaneous coronary interventions 2 | 01 September 2003 |
| Paroxysmal atrial fibrillation: evolving ablative approaches. | C. Pappone (Milan, IT) | Atrial Fibrillation - New concepts | 31 August 2003 |
| Pre-hospital thrombolysis with rescue angioplasty: as efficient as direct angioplasty? | J.M. Juliard (Paris, FR) | Optimal reperfusion therapy in acute myocardial infarction: the debate lives on | 01 September 2003 |
| Primary optimal percutaneous coronary intervention versus facilitated intervention (tenecteplase plus stenting) in patients with ST-elevated acute myocardial infarction (GRACIA-2) | F. Fernandez-Avilés (Valladolid, ES) | Hot Line II acute coronary syndromes / percutaneous coronary interventions 2 | 01 September 2003 |
| Risk stratification | C. Hamm (Bad Nauheim, DE) | Therapeutic options in non-ST segment elevation acute coronary syndromes | 01 September 2003 |
| Sirolimus-eluting stent in long lesions: direct stenting versus predilatation (E-SIRIUS) | J. Schofer (Hamburg, DE) | Hot Line II acute coronary syndromes / percutaneous coronary interventions 2 | 01 September 2003 |
| Standardization and quantification in echocardiography | W. Fehske (Cologne, DE) | Ultrasound in private practice | 02 September 2003 |
| The evolving European perspective on biventricular devices | D. Gras (Nantes, FR) | Update on guidelines for pacemakers and implantable cardiac-defibrillators | 03 September 2003 |
| The impact of transoesophageal echocardiography on daily clinical practice | P. Hanrath (Aachen, DE) | Edler and Hertz, the fathers of echocardiography - 50th anniversary session | 01 September 2003 |
| The ultrasound stethoscope for practitioners? | J. R.T.C. Roelandt (Rotterdam, NL) | New strategies in the diagnosis of heart failure | 31 August 2003 |
| Thrombectomy or protecting devices in direct angioplasty? | G. Stone (New York, US) | Optimal reperfusion therapy in acute myocardial infarction: the debate lives on | 01 September 2003 |
| Two common clinical scenarios: aortic stenosis and left ventricular dysfunction. Moderate aortic stenosis in patients undergoing coronary revascularisation | B. Khandheria (Rochester, US) | Challenging issues in valvular heart disease: applying the guidelines | 31 August 2003 |
| Ultrasound: the stethoscope of the third millennium? | J.R.T.C. Roelandt (Rotterdam, NL) | ESC lecture on clinical cardiology. The denolin lecture | 02 September 2003 |